DV
Dividend Vision

ETF Comparison

AIQ vs HLTH: Which Is the Better Pick in 2026?

A head-to-head comparison of Global X Artificial Intelligence & Technology ETF and Tema Healthcare AI ETF covering yield, cost, risk, and income potential.

Data updated September 18, 2026

Visual comparison

Key metrics

Projected income on $10K

Projections assume the current yield and share price remain constant. Actual results will vary.

Total returns

100% reinvested · ex-date convention. Period returns use this fixed assumption, independent of chart settings.

AIQ has lagged HLTH over the shared window since Jul 2026, posting a 5.13% total return against 15.77%. Figures are total returns: price change plus every distribution reinvested.

Total return and risk statistics by fund. Each row is one fund; each column is one period or statistic.
SymbolSince Jul 2026
AIQ5.13%
HLTH15.77%

Total return with all distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date), split-adjusted, as of September 18, 2026. YTD and 1Y are cumulative; windows of one year or longer are annualized. “Since Jul 2026” measures every fund from July 21, 2026 — the start of shared available history — so all funds share one comparison window.

Side-by-side snapshot

Side-by-side snapshot. Each row is one metric; each column is one fund.
MetricAIQHLTH
Full nameGlobal X Artificial Intelligence & Technology ETFTema Healthcare AI ETF
IssuerGlobal XTema ETFs
Last Close$64.13 as of September 18, 2026$29.30 as of September 18, 2026
Distribution rate0.00%
Distribution Safety Score™ 69
Safety-Adjusted Yield 0.05%
Expense ratio0.68%0.75%
AUM$10.1B$8.67M
Distribution frequencySemi-AnnualNone
Underlying index
ObjectiveSeeks long-term capital appreciation through an actively managed portfolio of companies applying artificial intelligence across healthcare — including AI-driven drug discovery, diagnostics, medical imaging, medical devices, and healthcare IT platforms.
Asset classEquityEquity
Inception date05/11/201807/21/2026
Beta1.68
Last dividend$0.0004
Ex-dividend date06/29/2026

— Distribution rate, Safety-Adjusted Yield, last dividend, and ex-dividend date are not yet available because HLTH launched July 2026; these fields will populate after the first distribution.

Bottom lineWe won't call this one: HLTH launched July 2026, so there is not yet a track record to compare. Compare the strategy, cost and holdings in the sections above and treat any performance figures for the newer ETF as provisional.

Income calculator

See how much monthly income a hypothetical investment would generate in each ETF at current yields.

ETFs117
Total AUM$94.0B

ETFs and AUM reflect what Dividend Vision tracks — the issuer's full lineup may be larger.

Global X is known for developing thematic and alternative investment ETFs with a strong emphasis on income-generating strategies. Their 37-fund lineup spans diverse categories including covered call funds, SuperDividend income products, digital assets, commodities, and sector-specific investments, alongside traditional bond and risk-managed income options. Notable tickers like DIV, MLPA, and BCCC reflect their specialization in high-yield and alternative income strategies, positioning them as a provider focused on investors seeking yield-oriented and thematically-driven exposure.

See our curated list of related YouTube videos on AIQ.

ETFs13
Total AUM$3.80B

ETFs and AUM reflect what Dividend Vision tracks — the issuer's full lineup may be larger.

Tema ETFs is known for offering thematically focused and income-oriented strategies that target specific industries and trends rather than broad market exposure. The issuer's lineup spans both income-generating funds and thematic investments centered on sectors such as defense, healthcare, technology, and infrastructure, with tickers including ARMY, CANC, DSPY, HLTH, LAZR, NASA, and VOLT. Tema's approach appeals to investors seeking targeted exposure to niche market segments, combining specialized industry focus with dividend and yield strategies.

See our curated list of related YouTube videos on HLTH.

Want to go deeper?

Add these ETFs to a sample portfolio and forecast your dividend income over 5+ years — free to start, no credit card.

Quick verdict

AIQ (Global X Artificial Intelligence & Technology ETF) and HLTH (Tema Healthcare AI ETF) are both ETFs, but they take different approaches.

AIQ is cheaper with an expense ratio of 0.68% compared to 0.75%.

AIQ has $10.1B in assets vs $8.67M for HLTH, but HLTH only launched July 2026 — AUM comparisons will become more meaningful as it builds a track record.

Deep dive

Yield & income

On a $10,000 investment, AIQ has no reported distribution yield yet, so a monthly income estimate is not available, while HLTH has no reported distribution yield yet, so a monthly income estimate is not available, at current distribution rates.

AIQ yield0.00%
HLTH yield

Cost & efficiency

Over 10 years on $10,000, AIQ would cost approximately $680 in fees vs $750 for HLTH (simplified, not compounded). The $70.00 difference may be offset by yield or performance.

AIQ ER0.68%
HLTH ER0.75%

Strategy & risk

AIQ is an ETF built around technology exposure, while HLTH is an actively managed ETF built around healthcare exposure.

AIQ beta1.68
HLTH beta

Fund details

AIQ is managed by Global X (launched 05/11/2018) with $10.1B in assets. HLTH is managed by Tema ETFs (launched 07/21/2026) with $8.67M in assets.

AIQ AUM$10.1B
HLTH AUM$8.67M

Enjoyed this page?

Do us a favor — if you found this comparison useful, please share it with a friend researching dividend ETFs.

Frequently asked questions

Which of AIQ or HLTH pays more dividend income?

HLTH currently reports a distribution yield, while AIQ has not yet established a full distribution history. A direct income comparison is not yet meaningful — check back once both funds have published several consecutive distributions.

What is the difference between AIQ and HLTH?

AIQ (Global X Artificial Intelligence & Technology ETF) is an ETF built around technology exposure, while HLTH (Tema Healthcare AI ETF) is an actively managed ETF built around healthcare exposure. They are issued by Global X and Tema ETFs respectively.

Can I hold both AIQ and HLTH?

Yes — nothing prevents holding both. Whether the combination actually diversifies depends on how much the underlying exposures overlap, which isn't fully measurable from the data on this page; review each security's holdings, sector, and strategy before treating them as complementary.

Which has lower fees, AIQ or HLTH?

AIQ has an expense ratio of 0.68% while HLTH charges 0.75%. Lower fees mean more of your investment returns stay in your pocket over time.

How much income does $10,000 in AIQ vs HLTH generate?

At current rates, AIQ has not established a distribution history yet, so a monthly income estimate is not available. HLTH has not established a distribution history yet, so a monthly income estimate is not available.

Which has performed better historically, AIQ or HLTH?

AIQ has lagged HLTH over the shared window since Jul 2026, posting a 5.13% total return against 15.77%. Figures are total returns: price change plus every distribution reinvested. Past performance does not guarantee future results.

More comparisons to explore

AIQ vs HLTH — at a glance

Generated September 19, 2026.

Overview

AIQ and HLTH are both equity ETFs focused on artificial intelligence, but they take opposite approaches to scope and sector. AIQ is a broad, passively managed technology fund centered on AI with $10.1B in assets and 8 years of history. HLTH is a newly launched, actively managed healthcare fund that narrows the lens to AI applications within medicine and healthcare delivery, with $8.67M in assets.

How they differ

The biggest difference is scope: AIQ targets AI companies across all technology sectors—semiconductors, software, cloud infrastructure, and consumer tech—while HLTH limits itself to healthcare-specific AI use cases like drug discovery, medical imaging, diagnostics, and healthcare IT platforms. That strategic choice cascades into structure and size. AIQ is a passive fund with $10.1B backing its index methodology; HLTH is actively managed, launched 07/21/2026, with $8.67M currently and no disclosed distribution yield. AIQ charges 0.68% and trades with a 1.68 beta, meaning it tends to amplify broad market moves.

HLTH: Designed for investors seeking a concentrated bet on AI applications within healthcare specifically, who value active management to select thematic positions, and who can tolerate newer fund structures and lower asset bases.

Key risks to know

  • Concentration in AI-dependent companies. Both funds' returns hinge on the sustained profitability and adoption of AI by their underlying holdings. A slowdown in AI spending or margin compression from AI commoditization would pressure both portfolios.
  • AIQ's high beta and sector volatility. AIQ's 1.68 beta means it swings more sharply than the broad market during technology selloffs. Technology equities are volatile; that leverage amplifies drawdowns.
  • Holdings overlap and related-sector risk. Both funds may hold overlapping AI infrastructure and software names, amplifying concentration risk if the underlying theme underperforms.

Bottom line

If you want diversified AI exposure across technology sectors with a passive structure and established liquidity, AIQ offers a mature vehicle with broad thematic reach. If you're specifically convinced that AI will reshape healthcare and willing to accept active management, newer-fund risk, and tighter spreads in exchange for a focused healthcare thesis, HLTH provides that focused angle. Past performance does not predict future results.

AI-generated analysis for educational purposes only. Verify important details independently; past performance does not guarantee future results.

Learn the method

The metrics behind this comparison, explained in the Academy.

Still deciding? Compare them against your own portfolio

See how each ETF fits alongside your real holdings — forecast future income, analyze overlap, and gauge risk. Start a free 7-day Dividend Vision trial and make the call with your full portfolio in view.